Increasing Clinical Studies Propel Growth Of In Vitro Lung Model Market: A Game-Changing Factor in the In-Vitro Lung Model Market’s Future Growth
The in-vitro lung model market size is expected to see exponential growth in the next few years. It will grow to $1.16 billion in 2029 at a compound annual growth rate (CAGR) of 21.0%. The growth in the forecast period can be attributed to drug development needs, rise in preclinical testing, increasing awareness of respiratory toxicology, focusing on regenerative medicine, growing environmental concerns, increasing geriatric populations. Major trends in the forecast period include increased demand for drug testing, advancements in 3D printing technology, advancements in organ-on-chip technology, integration of AI and machine learning, integration of sensors and monitoring devices, expansion of applications beyond pharmaceuticals, development of disease-specific models.
Get Your Free Sample of The Global In-Vitro Lung Model Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp
Which Market drivers have played a significant role in driving the in-vitro lung model market?
The increase in clinical studies is expected to propel the growth of the in vitro lung model market going forward. Clinical trials refer to research studies that test how well new medical approaches work in people. The increase in clinical studies is driven by the growing need for advanced medical treatments, rising healthcare demands, and the pursuit of innovative solutions to complex health issues. In vitro lung models help in clinical trials by providing a controlled environment to study the effects of substances on lung tissue, aiding in drug testing, toxicity assessment, disease modeling, and understanding disease mechanisms. For instance, in January 2024, according to ClinicalTrials.gov, a US-based clinical trial registry, by the end of 2023, 477,230 clinical trials registered globally on ClinicalTrials.gov, an increase compared to 437,508 registered clinical trials in 2022. Therefore, the increase in clinical studies drives the in vitro lung model market.
What are the key segments within the in-vitro lung model market?
The in-vitro lung model market covered in this report is segmented –
1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model
2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures
2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report
Which key players are shaping the in-vitro lung model market?
Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH
Which transformative trends will shape the in-vitro lung model market landscape?
Major companies operating in the invitro lung model market are developing 3D respiratory tissue models to enhance their models' physiological relevance and complexity. 3D respiratory tissue models are created by culturing selected respiratory cells in a specialized environment, allowing them to assemble into a three-dimensional structure miming the respiratory system's function and morphology, providing a more physiologically relevant platform for research and drug testing. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, introduced EpiNasal, an innovative 3D respiratory tissue model made from primary human nasal epithelial cells. It replicates the three-dimensional structure and functionality of nasal epithelium, including mucus-producing goblet cells, functional tight junctions, and cilia that beat. The introduction of EpiNasal expands MatTek's portfolio of 3D respiratory tissue models. This model offers a comprehensive system for studying the effects of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.
How do regional factors impact the in-vitro lung model market, and which region is the largest contributor?
North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The In-Vitro Lung Model Market Report 2025 Offer?
The in-vitro lung model market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
An In-Vitro lung model is a scientific construct designed to imitate the cellular, structural, and functional properties of the human lung in a controlled laboratory environment. These models enable researchers to investigate illness development, discover biomarkers, and assess treatment efficacy. They are useful tools for better understanding lung biology, developing therapies, and improving health outcomes.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment